Drug Profile
MI 1544
Latest Information Update: 29 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antihormones; Contraceptives; Hormones
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 29 Apr 2002 No development reported - Preclinical for Cancer in Hungary (unspecified route)
- 30 Jun 1997 Two studies have been added to the pharmacodynamics section (538835 and 538836)
- 01 Feb 1995 Preclinical development for Cancer in Hungary (Unknown route)